News

New report calls for urgent action to avert antimicrobial resistance crisis

International organizations unite on critical recommendations to combat drug-resistant infections and prevent staggering number of deaths each year.

Read More...

NADP Annual Meeting, 22 May 2019, Paushuize, Utrecht ‘Accelerating antibiotic development in Europe’

NADP logo

The Netherlands Antibiotic Development Platform (NADP) is organizing its second annual meeting, titled ‘Accelerating antibiotic development in Europe’.

Read More...

Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics

Dutch biotechnology company Micreos announced it has secured €30 million in funding to accelerate the development of its endolysin technology, set to replace antibiotics. Proceeds are earmarked for the clinical development program of its endolysin XZ.700 and the USA launch of its breakthrough OTC Gladskin product for eczema.

Read More...

New ReAct Report: When the Drugs Don’t Work – Antibiotic Resistance as a Global Development Problem

Working antibiotics have given us a huge boost in quality of life over the last nine decades, but their importance and value is overlooked. Antibiotics play a crucial role in many more areas of life than most people imagine. This new report by ReAct and Dag Hammarskjöld Foundation looks at the state of global development...

Read More...

Romanian EU Presidency aims to strengthen Europe’s One Health approach to fighting antimicrobial resistance

Antimicrobial resistance (AMR) is widely recognized as one of the 21st century’s greatest threats to health, welfare and food security. Worldwide, an estimated 700 000 people die each year from drug-resistant infections. In the European Union (EU) and European Economic Area (EEA) alone, 33 000 lives are claimed each year, and these numbers are rising.

Read More...

Madam Therapeutics has been awarded a grant from the Netherlands Antibiotic Development Platform (NADP)

Madam Therapeutics announced that it is one of the four companies in the Netherlands that have been awarded a novel grant from the Netherlands Antibiotic Development Platform (NADP).

Read More...